Safety profile of bivalirudin in Chinese female patients undergoing percutaneous coronary intervention: a multi-center study

BACKGROUND: The present study aimed to comprehensively investigate the occurrence and risk factors of adverse events (AEs) or adverse drug reactions (ADRs) (especially for thrombocytopenia and bleeding) in Chinese female patients receiving bivalirudin during percutaneous coronary intervention (PCI)....

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fan, Liu, Xueying, Ran, Huazhong, Tang, Qiwei, Zhong, Cheng, Wu, Yanqing, Xiao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851799/
https://www.ncbi.nlm.nih.gov/pubmed/35172721
http://dx.doi.org/10.1186/s12872-022-02474-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851799/
https://www.ncbi.nlm.nih.gov/pubmed/35172721
http://dx.doi.org/10.1186/s12872-022-02474-3

Ejemplares similares